Avalanche Biotechnologies CEO Laurent Fischer's 2022 pay falls 68% to $2.9M
Avalanche Biotechnologies reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
Avalanche Biotechnologies reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, seven executives at Avalanche Biotechnologies received on average a compensation package of $1.3M, a 53% decrease compared to previous year.
Laurent Fischer, Chief Executive Officer, received $2.9M in total, which decreased by 68% compared to 2021. 66% of Fischer's compensation, or $1.9M, was in option awards. Fischer also received $329K in non-equity incentive plan, $646K in salary, as well as $2.1K in other compensation.
For fiscal year 2022, the median employee pay was $169,590 at Avalanche Biotechnologies. Therefore, the ratio of Laurent Fischer's pay to the median employee pay was 17 to one.
Setareh Seyedkazemi, Chief Development Officer, received a compensation package of $1.5M. 41% of the compensation package, or $629K, was in option awards.
Richard Beckman, Chief Medical Officer, earned $1.4M in 2022.
Kishor Peter Soparkar, Chief Operating Officer, received $1.3M in 2022, which decreases by 46% compared to 2021.
John Rakow, Chief Financial Officer, earned $1M in 2022.
Rupert D'Souza, Chief Financial Officer, received $636K in 2022, which increases by 14% compared to 2021.
Linda Rubinstein, Chief Financial Officer, earned $112K in 2022.
Related executives
Laurent Fischer
Avalanche Biotechnologies
Chief Executive Officer
Linda Rubinstein
Avalanche Biotechnologies
Chief Financial Officer
Richard Beckman
Avalanche Biotechnologies
Chief Medical Officer
Setareh Seyedkazemi
Avalanche Biotechnologies
Chief Development Officer
Kishor Soparkar
Avalanche Biotechnologies
Chief Operating Officer
Rupert D'Souza
Avalanche Biotechnologies
Chief Financial Officer
John Rakow
Avalanche Biotechnologies